Do ATP and UTP involve cGMP in positive inotropism on rat atria?

Babenko, 1997, Purinergic facilitation of ATP-sensitive potassium current in rat ventricular myocytes, Br. J. Pharmacol., 120, 631, 10.1038/sj.bjp.0700960 Bean, 1992, Pharmacology and electrophysiology of ATP-activated ion channels, Trends Pharmacol. Sci., 13, 87, 10.1016/0165-6147(92)90032-2 Beavo, 1990, Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors, Trends Pharmacol. Sci., 11, 150, 10.1016/0165-6147(90)90066-H Belles, 1987, Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide, Pflügers Arch. Eur. J. Physiol., 409, 582, 10.1007/BF00584657 Buchan, 1991, Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP, Br. J. Pharmacol., 104, 361, 10.1111/j.1476-5381.1991.tb12436.x Burnstock, 1985, Is there a basis for distinguishing two types of P2-purinoceptor?, Gen. Pharmacol., 16, 433, 10.1016/0306-3623(85)90001-1 Burnstock, 1987, P2-purinoceptor of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y- but not the P2x-purinoceptor, Br. J. Pharmacol., 90, 383, 10.1111/j.1476-5381.1987.tb08968.x Charlton, 1996, Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP, Br. J. Pharmacol., 119, 1301, 10.1111/j.1476-5381.1996.tb16038.x Diamond, 1985, A novel cyclic GMP-lowering agent, LY83583, blocks carbachol-induced cyclic GMP elevation in rabbit atrial strips without blocking the negative inotropic effects of carbachol, Can. J. Physiol. Pharmacol., 63, 908, 10.1139/y85-150 Dunn, 1988, Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens, Br. J. Pharmacol., 93, 243, 10.1111/j.1476-5381.1988.tb11427.x Escande, 1992, K+ channel openers and ‘natural’ cardioprotection, Trends Pharmacol. Sci., 13, 269, 10.1016/0165-6147(92)90083-I Fredholm, 1994, Nomenclature and classification of purinoceptors, Pharmacol. Rev., 46, 143 Fredholm, 1997, Towards a revised nomenclature for P1 and P2 receptors, Trends Pharmacol. Sci., 18, 79, 10.1016/S0165-6147(96)01038-3 Froldi, 1994, Dual effect of ATP and UTP on rat atria: which types of receptors are involved?, Arch. Pharmacol., 349, 381, 10.1007/BF00170884 Froldi, 1997, P2X-purinoceptors in the heart: actions of ATP and UTP, Life Sci., 60, 1419, 10.1016/S0024-3205(97)00093-3 Hagiwara, 1987, Specific binding of a novel compound, N-[2-(methylamino) ethyl]-5-isoquinolinesulfonamide (H-8) to the active site of cAMP-dependent protein kinase, Mol. Pharmacol., 31, 523 Hamada, 1990, Glibenclamide specifically blocks ATP-sensitive K+ channel current in atrial myocytes of guinea pig heart, Jpn. J. Pharmacol., 54, 473, 10.1254/jjp.54.473 Harper, 1975, Fentomole-sensitive radioimmunoassay for cyclic nucleotides, J. Cyclic Nucleotide Res., 1, 207 Hobbs, 1997, Soluble guanylate cyclase: the forgotten sibling, Trends Pharmacol. Sci., 18, 484, 10.1016/S0165-6147(97)90687-8 Klabunde, 1998, Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts, Cardiovasc. Res., 37, 676, 10.1016/S0008-6363(97)00251-4 Kojda, 1996, Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes, Circ. Res., 78, 91, 10.1161/01.RES.78.1.91 Lambrecht, 1992, PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses, Eur. J. Pharmacol., 217, 217, 10.1016/0014-2999(92)90877-7 Legssyer, 1988, ATP and other adenine compounds increase mechanical activity and inositol trisphosphate production in rat heart, J. Physiol., 401, 185, 10.1113/jphysiol.1988.sp017157 Lohmann, 1991, Signal transduction by cGMP in heart, Basic Res. Cardiol., 86, 503, 10.1007/BF02190700 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 19, 265, 10.1016/S0021-9258(19)52451-6 McLaren, 1998, Comparison of the actions of ATP and UTP at P2X1 receptors in smooth muscle of the rat-tail artery, Eur. J. Pharmacol., 351, 139, 10.1016/S0014-2999(98)00294-5 Michel, 1993, Distribution and characterisation of [3H] α,β-methylene ATP binding sites in the rat, Arch. Pharmacol., 348, 608, 10.1007/BF00167237 Nicholas, 1996, Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of an UDP-selective, an UTP-selective, and an ATP- and UTP-specific receptor, Mol. Pharmacol., 50, 224 O'Connor, 1991, Further subclassification of ATP receptors based on agonist studies, Trends Pharmacol. Sci., 12, 137, 10.1016/0165-6147(91)90530-6 Podraski, 1997, A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 receptor, Am. J. Pharmacol., 273, H2380 Pugazhenthi, 1990, Inhibitory effect of H-7, H-8 and polymyxin β on liver protein kinase C-induced phosphorylation of endogenous substrates, Biochem. Int., 20, 941 Ralevic, 1998, Receptors for purines and pyrimidines, Pharmacol. Rev., 50, 413 Scamps, 1990, The mechanism of positive inotropy induced by adenosine triphosphate in rat heart, Circ. Res., 67, 1007, 10.1161/01.RES.67.4.1007 Schulz, 1991, The expanding family of guanyl cyclases, Trends Pharmacol. Sci., 12, 116, 10.1016/0165-6147(91)90519-X Steiner, 1972, Radioimmunoassay for cyclic nucleotides, J. Biol. Chem., 247, 1106, 10.1016/S0021-9258(19)45621-4 Vanhoutte, 1996, X International Union of Pharmacology Recommendations for Nomenclature of New Receptor Subtypes, Pharmacol. Rev., 48, 1 von Kügelgen, 1990, Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP, Arch. Pharmacol., 342, 198, 10.1007/BF00166965 Wu, 1998, Activation of muscarinic K+ channels by extracellular ATP and UTP in rat atrial myocytes, J. Cardiovasc. Pharmacol., 31, 203, 10.1097/00005344-199802000-00005